Investor concerns over the renewable energy sector's near-term prospects were evident on Friday, with Adani Green Energy ...

Nuvama lists out 4 reasons why they have rated MphasiS Buy. However they have a revised the price target lower. Find out why?

Nuvama Wealth Management announced the date to declare its third-quarter FY2024-25 results on Friday, January 24. Shares were ...

The brokerage firm, Nuvama, has raised its target price for UltraTech Cement to Rs 11,574 per share while maintaining its ...

(Reuters) -Shares of Dr Reddy's Laboratories dropped 6% on Friday and were on track for their worst session in nearly nine ...

NewsVoir Mumbai Maharashtra [India] January 24 The modern workplace continues to evolve beyond aesthetics and UrbanWrk a ...

Brokerages praise UltraTech Cement's Q3 performance, foreseeing market share gains and future growth despite profit decline ...

India's Orient Cement reported a slump in third-quarter profit on Friday due to weak prices of the key construction material amid seasonally low demand.

Key aspects to monitor in the earnings report include the outlook for domestic demand and the trajectory of export growth, ...

According to a Moneycontrol poll of five brokerages, NTPC is likely to see an increase in revenue 9 percent to Rs 43,014 ...

Coforge’s strong performance in Q3 and solid TCV set up the base perfectly for 20 per cent-plus YoY growth in FY26, Nuvama said. Besides, margin expansion on lower ESOP costs should yield 25 per ...

The round saw participation from high-profile investors, including Tiger Global, Evolvence, Foundamental GmbH, Ashish Kacholia, Nikhil Kamath, Abhijit Pai, Sumeet Kanwar, Nuvama, and CapriGlobal.